AZACITIDINE IN COMBINATION WITH VENETOCLAX, GILTERITINIB, MIDOSTAURIN OR OTHER COMPOUNDS FOR TREATING LEUKEMIA OR MYELODYSPLASTIC SYNDROME
Provided herein are methods for using 5-azacytidine in combination with one or more additional agents to treat diseases and disorders including acute myeloid or myelogenous leukemia (AML). Other disease and disorders those associated with abnormal cell proliferation, myelodysplastic syndromes (MDS),...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; spa |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | DUNSHEE Diana R LOPES DE MENEZES Daniel E DAI Yumin BEACH Cl ROSE Shelonitda MACBETH Kyle FRATTINI Mark JANG Jessica |
| description | Provided herein are methods for using 5-azacytidine in combination with one or more additional agents to treat diseases and disorders including acute myeloid or myelogenous leukemia (AML). Other disease and disorders those associated with abnormal cell proliferation, myelodysplastic syndromes (MDS), abnormal cell proliferation, hematologic disorders, and immune disorders, among others.
En el presente documento se proporcionan métodos para usar 5-azacitidina en combinación con uno o más agentes adicionales para tratar enfermedades y trastornos que incluyen leucemia mieloide o mielógena aguda (LMA). Otras enfermedades y trastornos asociados con proliferación celular anormal, síndromes mielodisplásicos (SMD), proliferación celular anormal, trastornos hematológicos y trastornos inmunitarios, entre otros. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_MX2021015993A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>MX2021015993A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_MX2021015993A3</originalsourceid><addsrcrecordid>eNqNjE0OAUEQRmdjIbhDxZrETywsW3cxFd1V0l2DsRGRthIknMKpjcQBrL7k5b2vXbzNwVhScsQIxGAlLIiNkjDsSEvYIqOK9WY_gBV5xdjYTIsBBHKS1FSxySSCaInx22-kYpdg2TCN2FzxCjxWawxkvmKo0Yur08abpGQh1eyiBOwWrcvp-sy933aK_hLVlsP8uB_z83E651t-HcN-MpqMR-PZfD4107-kD7aeQDE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>AZACITIDINE IN COMBINATION WITH VENETOCLAX, GILTERITINIB, MIDOSTAURIN OR OTHER COMPOUNDS FOR TREATING LEUKEMIA OR MYELODYSPLASTIC SYNDROME</title><source>esp@cenet</source><creator>DUNSHEE Diana R ; LOPES DE MENEZES Daniel E ; DAI Yumin ; BEACH Cl ; ROSE Shelonitda ; MACBETH Kyle ; FRATTINI Mark ; JANG Jessica</creator><creatorcontrib>DUNSHEE Diana R ; LOPES DE MENEZES Daniel E ; DAI Yumin ; BEACH Cl ; ROSE Shelonitda ; MACBETH Kyle ; FRATTINI Mark ; JANG Jessica</creatorcontrib><description>Provided herein are methods for using 5-azacytidine in combination with one or more additional agents to treat diseases and disorders including acute myeloid or myelogenous leukemia (AML). Other disease and disorders those associated with abnormal cell proliferation, myelodysplastic syndromes (MDS), abnormal cell proliferation, hematologic disorders, and immune disorders, among others.
En el presente documento se proporcionan métodos para usar 5-azacitidina en combinación con uno o más agentes adicionales para tratar enfermedades y trastornos que incluyen leucemia mieloide o mielógena aguda (LMA). Otras enfermedades y trastornos asociados con proliferación celular anormal, síndromes mielodisplásicos (SMD), proliferación celular anormal, trastornos hematológicos y trastornos inmunitarios, entre otros.</description><language>eng ; spa</language><subject>CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, ORSURGICAL ARTICLES ; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR ; HUMAN NECESSITIES ; HYGIENE ; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICALARTICLES ; MEDICAL OR VETERINARY SCIENCE ; METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS INGENERAL ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220406&DB=EPODOC&CC=MX&NR=2021015993A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220406&DB=EPODOC&CC=MX&NR=2021015993A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DUNSHEE Diana R</creatorcontrib><creatorcontrib>LOPES DE MENEZES Daniel E</creatorcontrib><creatorcontrib>DAI Yumin</creatorcontrib><creatorcontrib>BEACH Cl</creatorcontrib><creatorcontrib>ROSE Shelonitda</creatorcontrib><creatorcontrib>MACBETH Kyle</creatorcontrib><creatorcontrib>FRATTINI Mark</creatorcontrib><creatorcontrib>JANG Jessica</creatorcontrib><title>AZACITIDINE IN COMBINATION WITH VENETOCLAX, GILTERITINIB, MIDOSTAURIN OR OTHER COMPOUNDS FOR TREATING LEUKEMIA OR MYELODYSPLASTIC SYNDROME</title><description>Provided herein are methods for using 5-azacytidine in combination with one or more additional agents to treat diseases and disorders including acute myeloid or myelogenous leukemia (AML). Other disease and disorders those associated with abnormal cell proliferation, myelodysplastic syndromes (MDS), abnormal cell proliferation, hematologic disorders, and immune disorders, among others.
En el presente documento se proporcionan métodos para usar 5-azacitidina en combinación con uno o más agentes adicionales para tratar enfermedades y trastornos que incluyen leucemia mieloide o mielógena aguda (LMA). Otras enfermedades y trastornos asociados con proliferación celular anormal, síndromes mielodisplásicos (SMD), proliferación celular anormal, trastornos hematológicos y trastornos inmunitarios, entre otros.</description><subject>CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, ORSURGICAL ARTICLES</subject><subject>DISINFECTION, STERILISATION, OR DEODORISATION OF AIR</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICALARTICLES</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS INGENERAL</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjE0OAUEQRmdjIbhDxZrETywsW3cxFd1V0l2DsRGRthIknMKpjcQBrL7k5b2vXbzNwVhScsQIxGAlLIiNkjDsSEvYIqOK9WY_gBV5xdjYTIsBBHKS1FSxySSCaInx22-kYpdg2TCN2FzxCjxWawxkvmKo0Yur08abpGQh1eyiBOwWrcvp-sy933aK_hLVlsP8uB_z83E651t-HcN-MpqMR-PZfD4107-kD7aeQDE</recordid><startdate>20220406</startdate><enddate>20220406</enddate><creator>DUNSHEE Diana R</creator><creator>LOPES DE MENEZES Daniel E</creator><creator>DAI Yumin</creator><creator>BEACH Cl</creator><creator>ROSE Shelonitda</creator><creator>MACBETH Kyle</creator><creator>FRATTINI Mark</creator><creator>JANG Jessica</creator><scope>EVB</scope></search><sort><creationdate>20220406</creationdate><title>AZACITIDINE IN COMBINATION WITH VENETOCLAX, GILTERITINIB, MIDOSTAURIN OR OTHER COMPOUNDS FOR TREATING LEUKEMIA OR MYELODYSPLASTIC SYNDROME</title><author>DUNSHEE Diana R ; LOPES DE MENEZES Daniel E ; DAI Yumin ; BEACH Cl ; ROSE Shelonitda ; MACBETH Kyle ; FRATTINI Mark ; JANG Jessica</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_MX2021015993A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; spa</language><creationdate>2022</creationdate><topic>CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, ORSURGICAL ARTICLES</topic><topic>DISINFECTION, STERILISATION, OR DEODORISATION OF AIR</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICALARTICLES</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS INGENERAL</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>DUNSHEE Diana R</creatorcontrib><creatorcontrib>LOPES DE MENEZES Daniel E</creatorcontrib><creatorcontrib>DAI Yumin</creatorcontrib><creatorcontrib>BEACH Cl</creatorcontrib><creatorcontrib>ROSE Shelonitda</creatorcontrib><creatorcontrib>MACBETH Kyle</creatorcontrib><creatorcontrib>FRATTINI Mark</creatorcontrib><creatorcontrib>JANG Jessica</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DUNSHEE Diana R</au><au>LOPES DE MENEZES Daniel E</au><au>DAI Yumin</au><au>BEACH Cl</au><au>ROSE Shelonitda</au><au>MACBETH Kyle</au><au>FRATTINI Mark</au><au>JANG Jessica</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>AZACITIDINE IN COMBINATION WITH VENETOCLAX, GILTERITINIB, MIDOSTAURIN OR OTHER COMPOUNDS FOR TREATING LEUKEMIA OR MYELODYSPLASTIC SYNDROME</title><date>2022-04-06</date><risdate>2022</risdate><abstract>Provided herein are methods for using 5-azacytidine in combination with one or more additional agents to treat diseases and disorders including acute myeloid or myelogenous leukemia (AML). Other disease and disorders those associated with abnormal cell proliferation, myelodysplastic syndromes (MDS), abnormal cell proliferation, hematologic disorders, and immune disorders, among others.
En el presente documento se proporcionan métodos para usar 5-azacitidina en combinación con uno o más agentes adicionales para tratar enfermedades y trastornos que incluyen leucemia mieloide o mielógena aguda (LMA). Otras enfermedades y trastornos asociados con proliferación celular anormal, síndromes mielodisplásicos (SMD), proliferación celular anormal, trastornos hematológicos y trastornos inmunitarios, entre otros.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; spa |
| recordid | cdi_epo_espacenet_MX2021015993A |
| source | esp@cenet |
| subjects | CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, ORSURGICAL ARTICLES DISINFECTION, STERILISATION, OR DEODORISATION OF AIR HUMAN NECESSITIES HYGIENE MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICALARTICLES MEDICAL OR VETERINARY SCIENCE METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS INGENERAL PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | AZACITIDINE IN COMBINATION WITH VENETOCLAX, GILTERITINIB, MIDOSTAURIN OR OTHER COMPOUNDS FOR TREATING LEUKEMIA OR MYELODYSPLASTIC SYNDROME |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T10%3A09%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DUNSHEE%20Diana%20R&rft.date=2022-04-06&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EMX2021015993A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |